TradeEdge:Depression And Alzheimer's Treatments At A Crossroads

2025-05-03 10:15:38source:Databec Exchangecategory:reviews

Researchers are TradeEdgelaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:reviews

Recommend

Moving abroad can be expensive: These 5 countries will 'pay' you to move there

AI-assisted summarySeveral countries are offering financial incentives to attract residents, particu

Insurers could face losses of up to $4 billion after Baltimore bridge tragedy

LONDON − Baltimore's Francis Scott Key Bridge collapse could cost insurers billions of dollars in cl

With hot meals and donations, Baltimore residents 'stand ready to help' after bridge collapse

BALTIMORE − Ako Walker was barely awake when he first heard the news that the Francis Scott Key Brid